Time to Regulate Nanoparticle Safety?

It's not often that an industry volunteers for tighter regulation and oversight.

Written bySusan Gaidos
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© 2005 Elsevier

Transmission electron micrographs of multi-walled carbon nanotubes in human epidermal keratinocytes. (From N. Monteiro-Riviere et al., Toxicol Lett, 155:377–84, March 15, 2005.)

It's not often that an industry volunteers for tighter regulation and oversight. But that's just what happened this past June, when the Environmental Protection Agency hosted a meeting in Washington, DC, to discuss a voluntary pilot program aimed at collecting information on existing nanoscale materials in order to evaluate potential risks and exposures. The attendees, 150 scientists and officials representing industry, academia, government, and environmental and health advocacy groups, unanimously agreed such a system should be implemented.

But it won't be easy. Conventional approaches to risk assessment, toxicity screening, and ADME (absorption, distribution, metabolism, and excretion) modeling don't necessarily apply to nanoscale materials. Even nomenclature is a problem: Existing measures for regulating new chemical substances distinguish materials by name, not size. Thus, the Toxic Substances ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control